Indivior PLC- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Indivior PLC 公司

Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.

Indivior PLC簡介



公司代碼INDV

公司名稱Indivior PLC

上市日期Dec 24, 2014

CEOCiaffoni (Joseph J)

員工數量1030

證券類型Ordinary Share

年結日Dec 24

公司地址234 Bath Road

城市SLOUGH

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United Kingdom

郵編SL1 4EE

電話448043791090

網址https://www.indivior.com/en

公司代碼INDV

上市日期Dec 24, 2014

CEOCiaffoni (Joseph J)

Indivior PLC公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Christian Heidbreder

Chief Scientific Officer

246.51K

+22.61%

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+3.15%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

135.98K

--

Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.

Chief Legal Officer

71.52K

+61.33%

Mr. Patrick A. Barry

Chief Commercial Officer

31.38K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

20.64K

+5.56%

Ms. Juliet Thompson

Senior Non-Executive Independent Director

13.35K

+43.27%

Dr. Keith Humphreys

Non-Executive Independent Director

9.52K

+27.80%

Ms. Kathryn Barbara Hudson

Company Secretary

--

Ms. Cynthia (Cindy) Cetani

Chief Integrity and Compliance Officer

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Christian Heidbreder

Chief Scientific Officer

246.51K

+22.61%

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+3.15%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

135.98K

--

Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.

Chief Legal Officer

71.52K

+61.33%

Mr. Patrick A. Barry

Chief Commercial Officer

31.38K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

20.64K

+5.56%

收入明細

單位: USD更新時間: 4月6日週一

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

United States

267.00M

85.03%

Rest of World

47.00M

14.97%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 15 小時前

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.90%

Vanguard Portfolio Management, LLC

6.61%

Oaktree Capital Management, L.P.

5.87%

The Vanguard Group, Inc.

5.39%

Fuller & Thaler Asset Management Inc.

5.27%

其他

62.96%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.90%

Vanguard Portfolio Management, LLC

6.61%

Oaktree Capital Management, L.P.

5.87%

The Vanguard Group, Inc.

5.39%

Fuller & Thaler Asset Management Inc.

5.27%

其他

62.96%

股東類型

持股股東

佔比

Investment Advisor

37.34%

Investment Advisor/Hedge Fund

26.89%

Hedge Fund

26.65%

Research Firm

7.60%

Individual Investor

4.27%

Pension Fund

3.22%

Bank and Trust

0.48%

Family Office

0.19%

Sovereign Wealth Fund

0.10%

機構持股



更新時間: 4月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2026Q1

516

123.98M

102.46%

-10.66M

2025Q4

1

2.06K

0.00%

--

2025Q3

372

118.02M

94.53%

+2.51M

2025Q2

354

123.13M

98.21%

+4.02M

2025Q1

380

119.99M

96.15%

-1.70M

2024Q4

382

116.83M

93.64%

-10.43M

2024Q3

369

117.73M

91.72%

-15.91M

2024Q2

352

119.29M

90.10%

-8.99M

2024Q1

341

129.79M

96.57%

+3.79M

2023Q4

322

124.43M

92.28%

+2.93M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

16.82M

13.8%

+9.03M

+115.92%

Dec 31, 2025

Oaktree Capital Management, L.P.

7.11M

5.83%

-1.64M

-18.71%

Dec 31, 2025

The Vanguard Group, Inc.

5.45M

4.47%

+2.01M

+58.34%

Dec 31, 2025

Fuller & Thaler Asset Management Inc.

6.37M

5.23%

+3.20M

+101.00%

Dec 31, 2025

Madison Avenue Partners LP

6.28M

5.15%

--

Feb 17, 2026

Two Seas Capital LP

5.11M

4.19%

-4.14M

-44.79%

Dec 31, 2025

Millennium Management LLC

4.81M

3.94%

+2.47M

+105.61%

Mar 17, 2026

Morgan Stanley & Co. LLC

3.82M

3.13%

-1.77M

-31.64%

Dec 31, 2025

Sirovich (Matthew I.)

3.42M

2.81%

+249.62K

+7.87%

Sep 30, 2024

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Lattice Hartford Multifactor Small Cap ETF

1.11%

ProShares Ultra Nasdaq Biotechnology

0.51%

Federated Hermes MDT Small Cap Core ETF

0.47%

Janus Henderson Small Cap Growth Alpha ETF

0.43%

First Trust Multi-Manager Small Cap Opportunities ETF

0.38%

Invesco Nasdaq Biotechnology ETF

0.36%

Franklin US Small Cap Multifactor Index ETF

0.32%

First Trust Active Factor Small Cap ETF

0.31%

Vanguard US Multifactor ETF

0.27%

Pacer US Small Cap Cash Cows ETF

0.26%

Lattice Hartford Multifactor Small Cap ETF

佔比1.11%

ProShares Ultra Nasdaq Biotechnology

佔比0.51%

Federated Hermes MDT Small Cap Core ETF

佔比0.47%

Janus Henderson Small Cap Growth Alpha ETF

佔比0.43%

First Trust Multi-Manager Small Cap Opportunities ETF

佔比0.38%

Invesco Nasdaq Biotechnology ETF

佔比0.36%

Franklin US Small Cap Multifactor Index ETF

佔比0.32%

First Trust Active Factor Small Cap ETF

佔比0.31%

Vanguard US Multifactor ETF

佔比0.27%

Pacer US Small Cap Cash Cows ETF

佔比0.26%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據